泡型棘球蚴病患者血浆寄生虫游离DNA可作为诊断与治疗状态指标
该研究采用DNA测序法检测149份血浆样本中的寄生虫游离DNA(cfDNA),包括105例泡型棘球蚴病(AE)、16例囊型棘球蚴病、4例肝癌、4例胆结石和20名健康志愿者。结果显示,术前AE患者血浆中均检出不同读取数的棘球属特异性cfDNA(Em-cfDNA),而非AE患者和健康志愿者均为阴性;Em-cfDNA对AE诊断具有良好敏感性和特异性,其水平对评估手术疗效和反映术前病灶大小有参考价值。
要点
- 基于测序检测血浆Em-cfDNA在术前AE患者中均检出,非AE及健康者均阴性。
- Em-cfDNA对AE诊断具有良好敏感性和特异性。
- Em-cfDNA水平对评估手术疗效和反映术前病灶大小有参考价值。
核心结论
- 基于测序监测Em-cfDNA可作为AE的有力诊断指标用于临床。
- 该液体活检方法在监测干预后AE患者疾病状态方面具有很大潜力。
研究设计与样本
- 研究分析了149份血浆样本,包括105例AE、16例囊型棘球蚴病、4例肝癌、4例胆结石和20名健康志愿者。
- 采用基于DNA测序的方法检测样本中的棘球属特异性cfDNA(Em-cfDNA)序列。
主要发现
- 术前AE患者血浆中100%可检出不同读取数的Em-cfDNA。
- 所有非AE患者和健康志愿者均为阴性。
- Em-cfDNA对AE诊断具有良好敏感性和特异性。
- Em-cfDNA水平对评估AE病灶手术干预疗效有参考价值。
- Em-cfDNA水平可反映术前AE患者病灶大小的有意义信息。
临床怎么用
- 可考虑将基于测序的血浆Em-cfDNA检测用于AE的临床诊断。
- 可利用Em-cfDNA水平辅助评估AE手术干预的疗效。
- 可利用Em-cfDNA水平辅助了解术前AE患者的病灶大小信息。
- 对干预后AE患者,可探索采用该液体活检方法监测疾病状态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Alveolar echinococcosis (AE) is a serious parasitic disease caused by the larvae of Echinococcus multilocularis. It is the less common but substantially more deadly of the 2 major echinococcosis diseases that can occur globally but are concentrated in central Asia. METHODS: We analyzed parasite circulating cell-free DNA (cfDNA) in 149 plasma samples using a DNA sequencing-based method (105 AE, 16 cystic echinococcosis, 4 liver cancer, 4 gallstones, and 20 healthy volunteers). After identifying the Echinococcus-specific cfDNA (Em-cfDNA) sequences in the samples, we determined whether Em-cfDNA could be used for AE diagnosis and as a potential indicator of the effectiveness of surgical treatment. We also examined potential associations between Em-cfDNA levels and clinical features of AE patients. RESULTS: Our work demonstrates that varying reads of Em-cfDNA were detectable in the plasma of 100% of preoperative AE patients and that all of the non-AE patients and healthy volunteers were negative. Em-cfDNA has good sensitivity and specificity for the diagnosis of AE. We also found that Em-cfDNA levels apparently have reference value for evaluating the therapeutic efficacy of surgery interventions for AE lesions. Finally, our analysis revealed that Em-cfDNA levels can reflect meaningful information about lesion size in preoperative AE patients. CONCLUSIONS: We demonstrate that sequencing-based monitoring of Em-cfDNA can be used in the clinic as a powerful diagnostic indicator for AE. We also note that there is a strong potential for use of this liquid-biopsy method to monitor ongoing disease status in postintervention AE patients.
引用
- Fan H, Gai W, Zhang L, et al. Parasite Circulating Cell-free DNA in the Blood of Alveolar Echinococcosis Patients as a Diagnostic and Treatment-Status Indicator. Clin Infect Dis. 2021. PMID: 33146713. doi:10.1093/cid/ciaa1679
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。